Related by context. All words. (Click for frequent words.) 76 fosbretabulin 75 Phase Ib study 74 Phase 1a clinical 74 preclinical efficacy 74 oral prodrug 73 multicenter Phase II 73 Aflibercept 73 CRLX# 72 phase Ib 72 PHX# 72 pharmacokinetic PK 72 phase IIb clinical 72 Alocrest 72 phase IIa 72 Phase IIIb clinical 72 Phase IIb III 72 Phase 2a clinical 71 phase IIa clinical 71 Phase 1b trial 71 liposomal formulation 71 Spiegelmer ® 71 Phase Ia 71 IMA# 71 Tarceva TM 71 Capesaris 71 Phase #b/#a 71 Phase 2a trial 71 Omacetaxine 71 Phase Ib II 71 MAGE A3 ASCI 71 GLP toxicology studies 71 Phase Ib clinical 71 GW# [003] 71 velafermin 71 TBC# 71 Phase IIa clinical 71 Phase #/#a 70 JAK inhibitor 70 phase IIIb 70 OHR/AVR# 70 Phase IIb clinical trials 70 evaluating tivozanib 70 Phase IIa trial 70 phase IIb III 70 Archexin 70 PEG IFN 70 ELACYT 70 OvaRex R 70 Luteinizing Hormone Releasing Hormone 70 alvespimycin 70 LymphoStat B TM 70 PSMA ADC 70 SUCCEED trial 70 Phase #b/#a trial 70 Panzem R NCD 70 Tesetaxel 70 ADVANCE PD 70 Phase III ADT 70 pharmacokinetics PK 70 CBLC# 70 orally inhaled migraine 70 trastuzumab DM1 T DM1 70 forodesine 70 FOLOTYN ® 70 multicenter randomized placebo controlled 70 ORMD 70 KRN# 70 Initiated Phase 69 Cloretazine ® 69 Traficet EN 69 PDX pralatrexate 69 Cloretazine 69 randomized controlled Phase 69 Onconase 69 NP2 Enkephalin 69 sorafenib Nexavar 69 II Clinical Trial 69 clevidipine 69 rALLy trial 69 multicenter Phase 69 IMPACT DCM 69 Dacogen injection 69 Androxal TM 69 oral deforolimus 69 cannabinor 69 oral picoplatin 69 phase Ib clinical 69 Renal Cell Carcinoma RCC 69 Ozarelix 69 IIa trial 69 trastuzumab emtansine T DM1 69 YONDELIS 69 CINQUIL 69 Proellex TM 69 demonstrated antitumor activity 69 Phase 1b clinical 69 Phase III Clinical Trial 69 Degarelix 69 Quinamed 69 Safinamide 69 Inhalation Solution 69 dose escalation clinical 69 Multiple Ascending Dose 69 Iloperidone 69 vidofludimus 69 AZILECT ® 69 KNS # 69 Prosaptide 69 Aplidin 69 HuMax CD4 69 BAL# [002] 69 relapsed MM 69 Phase IIA 69 Zybrestat 69 BRIM3 69 sitaxsentan 69 DermaVir Patch 69 Randomized Phase 69 Ophena TM 69 Zemplar Capsules 69 preclinically 69 EDEMA3 69 inhaled AAT 69 elacytarabine 69 RhuDex ® 69 novel oral anticoagulant 69 Phase #b/#a clinical 69 PDE4 inhibitor 69 orBec 69 Diabetic Macular Edema DME 69 Plicera 68 riociguat 68 oral ridaforolimus 68 mapatumumab 68 prucalopride 68 ONCONASE R 68 preclinical pharmacokinetic 68 Kahalalide F 68 Medidur TM FA 68 CRMD# 68 HuMax EGFr 68 torezolid phosphate 68 Phase 2b study 68 Xanafide 68 desvenlafaxine succinate 68 Tezampanel 68 Prostate AdenoCarcinoma Treatment 68 IMPACT IMmunotherapy 68 Proxinium TM 68 lorvotuzumab mertansine 68 Phase IIIb 68 multicenter phase 68 phase IIb trial 68 ADAGIO study 68 Deforolimus 68 Ambrisentan 68 oral renin inhibitor 68 Hsp# Inhibitor 68 Phase III psoriasis 68 Phase III multicenter 68 Kamada AAT 68 Phase 1b clinical trials 68 CTAP# Capsules 68 Xcytrin R 68 intranasal formulation 68 Phase 2a 68 Aclidinium 68 ganetespib 68 Temsirolimus 68 PRT# 68 phase IIb 68 antibody MAb 68 pharmacokinetic PK profile 68 neratinib 68 oral rivaroxaban 68 elotuzumab 68 Pivotal Phase III 68 pharmacodynamic PD 68 Perforomist ™ Inhalation Solution 68 Elagolix 68 Tanespimycin 68 docetaxel Taxotere ® 68 NSABP B 68 GOUT 68 virus HCV protease inhibitor 68 CHAMPION PCI 68 davunetide intranasal AL 68 huC# DM4 68 Virulizin ® 68 oral taxane 68 Meets Primary Endpoint 68 controlled multicenter Phase 68 Pazopanib 68 HDL Selective Delipidation 68 evaluating REVLIMID 68 urocortin 2 68 huN# DM1 68 Factor VIIa 68 INCB# [001] 68 Teriflunomide 68 HGS ETR1 68 Pafuramidine 68 teriflunomide 68 Sym# 68 evaluating Prochymal 68 dose escalation Phase 68 PRTX 68 histamine dihydrochloride 68 Chemophase 68 RhuDex 68 Vidaza azacitidine 68 lomitapide 68 Onrigin 68 Cinryze ™ 68 TRO# 68 Ceflatonin R 68 ZACTIMA 68 GAMMAGARD 68 galiximab 68 paclitaxel poliglumex 68 histone deacetylase inhibitor 68 Exherin TM 68 generation purine nucleoside 68 Glufosfamide 68 Ophena 68 Phase 2b Trial 67 trodusquemine 67 LibiGel ® 67 Phase 2b Clinical Trial 67 phase 2a 67 including eniluracil ADH 67 PANVAC VF 67 somatostatin analog 67 DAVANAT 67 Urocidin 67 TG# [003] 67 EDEMA3 trial 67 BrachySil TM 67 Pimavanserin 67 SUTENT ® 67 plasma kallikrein inhibitor 67 afamelanotide 67 CLORETAZINE TM VNP#M 67 pain palliation 67 Carfilzomib 67 AzaSite Plus 67 IIa clinical trial 67 BRIM2 67 Darusentan 67 TMC# C# 67 RezularTM 67 NV1FGF 67 Mipomersen 67 BRILINTA 67 Novolimus 67 multicentre randomized 67 farletuzumab 67 Dose Ranging Study 67 mertansine 67 HGS# 67 lexidronam injection 67 midstage clinical 67 tolevamer 67 orally dosed 67 Phase IIb Trial 67 HGS ETR2 67 metaglidasen 67 phase IIb study 67 LAB CGRP 67 Dalbavancin 67 azilsartan medoxomil 67 OvaRex 67 recurrent herpes labialis 67 DCCR 67 CEQ# 67 leading oral taxane 67 dose escalation trial 67 Iluvien TM 67 Cleviprex TM clevidipine 67 compound AEZS 67 pharmacodynamics PD 67 Annamycin 67 Personalized Immunotherapy 67 epoetin alpha 67 VNP#M 67 depsipeptide 67 TLK# 67 TELINTRA 67 EGS# 67 lucinactant 67 Silodosin 67 EXPAREL TM 67 Telbivudine 67 inhibitor RG# 67 Fibrillex 67 ORENCIA ® 67 Bezielle 67 Melphalan 67 viral kinetics 67 Dual Opioid 67 SinuNase ™ 67 cariprazine 67 dextofisopam 67 investigational oral hepatitis C 67 somatostatin analogue 67 Phase Ib 67 ribavirin RBV 67 Nitazoxanide 67 ToGA 67 APEX PD 67 refractory gout 67 immunotherapeutic vaccine 67 ruxolitinib 67 R roscovitine 67 randomized Phase IIb 67 maximally tolerated dose 67 Zenvia ™ 67 balsalazide tablet 67 Pharmacokinetics PK 67 LEVADEX ™ 67 Initiates Phase II 67 fluticasone furoate 67 Cloretazine R VNP#M 67 Fibrin Pad 67 Clolar ® 67 Vernakalant 67 Zenvia Phase III 67 Ereska 67 Phase IIB 67 Mycophenolate Mofetil 67 beta 1a 67 Sunovion 67 BARACLUDE ® 67 Vicriviroc 67 nonclinical studies 67 aclidinium 67 pan HDAC inhibitor 67 bortezomib Velcade 67 Immunotherapeutic 67 anticancer compound 67 cMET 67 Trofex 67 HCV SPRINT 67 EOquin TM 67 registrational trial 67 placebo controlled clinical 66 thorough QT 66 ritonavir boosted 66 Kepivance 66 CHARISMA trial 66 thalidomide Thalomid 66 Genz # 66 Romidepsin 66 STEDESA 66 clinical pharmacology studies 66 PEG SN# 66 refractory chronic lymphocytic 66 STRIDE PD 66 Phase III Pivotal 66 JAK2 inhibitor 66 subcutaneously administered 66 multicenter Phase III 66 SNT-MC#/idebenone 66 Pegloticase 66 viral kinetic 66 CALGB # [002] 66 PI3K/Akt pathway inhibitor 66 budesonide foam 66 ChronVac C R 66 Initiate Clinical Trial 66 Phase Ib clinical trials 66 deforolimus 66 radezolid 66 UPLYSO 66 Arikace 66 paclitaxel Taxol R 66 vapreotide acetate 66 lead Aganocide compound 66 ascending dose 66 Ropinirole 66 AEGR 66 Phase 1b 66 Pemetrexed 66 Prospective Randomized 66 pomalidomide 66 AVASTIN 66 Zalypsis 66 gemcitabine Gemzar ® 66 alemtuzumab Campath 66 Completes Patient Enrollment 66 GRN# 66 administered subcutaneously 66 SPRYCEL ® 66 recurrent glioblastoma multiforme 66 PEGylated interferon 66 brivaracetam 66 Combination REOLYSIN R 66 dextromethorphan quinidine 66 Achieves Primary Endpoint 66 Akt inhibitor 66 Begins Dosing 66 OvaRex ® MAb 66 IRX 2 66 favorable pharmacokinetic profile 66 EVIZON TM 66 rilonacept 66 Amrubicin 66 Aurora Kinase 66 solithromycin 66 miconazole Lauriad ® 66 Anidulafungin 66 dual endothelin receptor antagonist 66 axitinib 66 R#/MEM # 66 MERLIN TIMI 66 Fludara ® 66 OncoVEX GM CSF 66 NXL# 66 confirmatory Phase III 66 PrevOnco 66 CIMZIA TM 66 SinuNase TM 66 AIR CF1 66 GLP1 agonist 66 targeted radiotherapeutic 66 Ziprasidone 66 Triapine R 66 lumiliximab 66 CA9 SCAN 66 Acute Ischemic Stroke 66 double blinded placebo 66 Qutenza TM 66 antiviral efficacy 66 Sprycel dasatinib 66 pharmacokinetic equivalence 66 ularitide 66 cystinosis patients 66 TRX1 66 NPC 1C 66 metastatic castration resistant 66 Epratuzumab 66 Zoraxel 66 XL# SAR# 66 IL# PE#QQR 66 histone deacetylase HDAC inhibitor 66 orally bioavailable 66 ATL# [001] 66 pharmacokinetic pharmacodynamic 66 IIa trials 66 RE LY 66 dasatinib Sprycel ® 66 methylnaltrexone bromide 66 icatibant 66 Cethromycin 66 CYT# potent vascular disrupting 66 Phase #/#a trial 66 Civacir 66 OVATURE 66 indibulin 66 Vitaxin 66 ZOLINZA 66 L BLP# 66 DEB# 66 alvimopan 66 compound INCB# 66 tanespimycin 66 CIMZIA TM certolizumab pegol 66 ATL/TV# 66 metastatic malignant 66 Triapine 66 Matrix Phase 2b 66 RSD# oral 66 IIa clinical 66 HORIZONS AMI 66 non nucleoside inhibitor 66 Elvitegravir 66 LCP Tacro TM 66 trastuzumab DM1 66 Pancreas Cancer Vaccine 66 basal bolus regimen 66 HuMax TAC 66 TRANSFORMS 66 hPAM4 66 radiation sensitizer 66 HQK 66 tubulin inhibitor 66 OncoVex 66 wilate ® 66 DermaVir 66 PSN# [002] 66 investigational antiplatelet agent 66 Tyrima 66 CR# vcMMAE 66 oral salmon calcitonin 66 AZILECT R 66 diclofenac sodium 66 Glybera R 66 BEMA Granisetron 66 Successfully Completes Phase 66 acetonide FA 66 inhalation powder 66 rALLy clinical trial 66 ongoing Phase 1b 66 oral beclomethasone dipropionate 66 Myocet 66 AAG geldanamycin analog 66 NOX E# 66 ABSORB trial 66 Dacogen decitabine 66 ARIKACE 66 Angiocept 66 diarrhea predominant irritable 66 Raptiva ® 66 OLYMPIA registry 66 Phase 1a 66 Plenaxis TM 66 Diabetic Neuropathy 66 TransVax TM 66 randomized Phase 2b 66 Aplidin R 66 treatment naive genotype 66 pertuzumab 66 Phase III confirmatory 66 Bazedoxifene 66 GSK# [002] 66 MEK inhibitor RDEA# 66 acyclovir Lauriad R 66 humanised monoclonal antibody 66 Blinatumomab 66 SAR# [004] 66 PNT# 66 bepotastine besilate nasal spray 66 Cannabinor 66 rasagiline tablets 66 Files Investigational 66 arsenic trioxide injection 66 HuMax CD# 66 YONDELIS R 66 BrachySil 66 Phase 2b trial 66 ON #.Na 66 omacetaxine mepesuccinate 66 USL# 66 Squalamine 65 nucleotide analog 65 Phase 2b Study 65 double blinded randomized 65 Azacitidine 65 palonosetron 65 subcutaneous SC 65 masitinib 65 CCR5 antagonist 65 polymerase inhibitor 65 ACOMPLIA R 65 GLYX 65 MGd 65 alfa 2a 65 Cimzia TM 65 vemurafenib 65 relapsed MCL 65 Tovaxin TM 65 prostate cancer mCRPC 65 Metastatic Melanoma 65 ZEVALIN ® 65 delafloxacin 65 Laquinimod 65 DDP# 65 PEG uricase 65 Aloxi injection 65 apricitabine ATC 65 Iluvien ® 65 Pharmacokinetic 65 PNP inhibitor 65 ENMD # 65 bioequivalency 65 oral talactoferrin 65 Pharmacokinetic Study 65 Randomized Phase II 65 obatoclax 65 Tolvaptan 65 VIR# 65 Dabigatran etexilate 65 inhaled liposomal ciprofloxacin 65 BARACLUDE R 65 Myelodysplastic Syndrome MDS 65 GRNVAC1 65 PS# DARA 65 PROVENGE sipuleucel T 65 Alzhemed TM 65 selective androgen receptor modulator 65 PROMACTA 65 BrachySil ™ 65 Velcade bortezomib 65 Presents Preclinical Data 65 reslizumab 65 Ocrelizumab 65 pegylated liposomal doxorubicin 65 eniluracil 65 AZX# 65 Preclinical Study 65 BENICAR HCT 65 Bayer HealthCare Onyx Pharmaceuticals 65 RE LY ® 65 BioNumerik 65 Aganocide 65 plasma pharmacokinetics 65 Elitek 65 posaconazole 65 ZK EPO 65 oral methylnaltrexone 65 colesevelam HCl 65 Pivotal Study 65 Solorel TM 65 LymphoStat B belimumab 65 aurora kinase 65 Evoltra ® 65 1mg 2mg 65 ACTEMRA TM 65 Investigational Compound 65 goserelin 65 rhIGF-I/rhIGFBP-3 65 ® pioglitazone HCl 65 dalbavancin 65 varespladib 65 liposomal amphotericin B 65 p# inhibitor 65 Pharmacodynamic 65 Daclizumab 65 baminercept 65 ATPace TM 65 Alexza Staccato 65 efaproxiral 65 APTIVUS 65 MEND CABG 65 Phase IIb clinical 65 G#DT 65 Epirubicin 65 blinded randomized placebo controlled 65 Initiate Phase 65 Golimumab 65 prospective randomized multicenter 65 Afatinib 65 personalized cellular immunotherapy 65 vosaroxin 65 ALGRX 65 immune modulatory 65 Anthim 65 GFT# 65 Vinorelbine 65 PROSTVAC VF 65 oral treprostinil 65 Simulect 65 Altastaph 65 Hepatotoxicity 65 BNC# 65 Fingolimod 65 PRIMO CABG 65 adefovir dipivoxil 65 QLT# 65 cisplatin gemcitabine 65 Allovectin 7 65 vinca alkaloid 65 RAPTIVA 65 cathepsin K inhibitor 65 Ceflatonin 65 hyaluronidase enzyme 65 RELOVAIR ™ 65 pivotal bioequivalence 65 GMX# 65 BiTE R 65 candidate TNFerade biologic 65 Proquin XR 65 StemEx R 65 BEMA TM Fentanyl 65 mTOR inhibition 65 TH# [003] 65 omega interferon 65 Tyrosine Kinase Inhibitor 65 PrevOnco ™ 65 PEGINTRON TM 65 Muraglitazar 65 pharmacokinetic characteristics 65 nucleoside analog 65 ASCO abstract 65 2 methoxyestradiol 65 LB# [003] 65 investigational HCV polymerase 65 receptor tyrosine kinase inhibitor 65 Cand5 65 long acting muscarinic 65 Denufosol 65 mg/m2 cohort 65 ACAPODENE 65 RSD# 65 Phase III HEAT 65 amifostine 65 Kevetrin ™ 65 interferon gamma 1b 65 pharmacokinetic studies 65 PROSTVAC TM 65 CANCIDAS 65 octreotide acetate 65 adenosine injection 65 NeuroSTAT ® 65 Panzem R 65 Aptivus ® 65 AFREZZA TM 65 pharmacodynamic properties 65 Initiates Clinical Trial 65 vascular disrupting agents 65 Phase Ib IIa 65 AEG# 65 Q#IR 65 Tasimelteon 65 IPL# 65 ozarelix 65 Sudhir Agrawal D.Phil 65 Rigel R# 65 MYCAMINE 65 Alvesco R 65 Phase III Psoriasis 65 Phase IIb trials 65 TMC# [002] 65 novel histone deacetylase 65 Aviptadil 65 Presents Preclinical 65 RE LY trial 65 NVA# 65 micafungin 65 CRD5 65 Initiates Clinical 65 aclidinium bromide 65 Dasatinib 65 OMP #M# 65 Retacrit 65 humanized monoclonal 65 aleglitazar 65 alefacept 65 EOquin 65 ROTARIX 65 ospemifene 65 Pivotal Phase 65 liposome injection 65 oral RSD# 65 Neurodex 65 IMC #B 65 cell lymphoma CTCL 65 Lenocta 65 Trandolapril 65 Neuvenge 65 Guanilib 65 pioglitazone HCl 65 generation antisense inhibitor 65 Saforis 65 successfully commercialize Iluvien 65 MIRCERA 65 Thiovir 65 ocular formulation 65 LibiGel Phase III 65 alemtuzumab MS 65 denileukin diftitox 65 GSK# [001] 65 ESBA# 65 GALNS 65 Elocalcitol 65 MGN# 65 TRANSDUR Bupivacaine 65 personalized immunotherapy 65 apricitabine 65 TO AVOID PREGNANCY WHILE 65 dose escalation phase 65 Targretin capsules 65 MKC# MT 65 Azedra TM 65 tipifarnib 65 LUMINATE 65 bortezomib Velcade R 65 vinorelbine tartrate 65 PF # [002] 65 QTc prolongation 65 dose cohort 65 Catena ® 65 mitogen activated ERK kinase 65 OMNARIS Nasal Spray 64 EmbraceAC 64 Valortim ® 64 BLA filing 64 stated Michelle Berrey 64 bosutinib 64 OMNARIS HFA 64 cediranib 64 recurrent glioma 64 Hyphanox 64 sorafenib tablets 64 Liposomal 64 Solazed TM 64 inhaled iloprost 64 Fabry Disease 64 Darinaparsin 64 Troxatyl 64 Microplasmin 64 INCB# [002] 64 Elafin 64 crizotinib PF # 64 CLARITY study 64 Sipuleucel T 64 abatacept Orencia 64 LE SN# 64 Rebif ® 64 Clinical Trial Results 64 SCH # 64 zanolimumab 64 Dr. Fahar Merchant 64 PEGASYS ® 64 enzastaurin 64 ASSERT trial 64 AIR2 Trial 64 candidate CRLX# 64 Zenvia TM 64 briakinumab 64 Prodarsan ® 64 Aryplase 64 RAV# 64 rhITF 64 Keppra XR 64 oral antiviral 64 MEND CABG II 64 SNT MC# 64 Aurexis 64 RE COVER 64 therapeutic monoclonal antibody 64 DU #b 64 Fulvestrant 64 formerly LymphoStat B 64 octreotide implant 64 Placebo Controlled Trial 64 cetuximab Erbitux ® 64 Granted Orphan Drug 64 ara C 64 Actimmune ® 64 Telatinib 64 Randomized Evaluation 64 PROVENGE ® 64 Oral NKTR 64 Sufentanil 64 5 fluorouracil leucovorin 64 Azedra 64 CCR5 mAb 64 Valtropin 64 initiated Phase Ib 64 novel VDA molecule 64 IMPDH inhibitor 64 cetrorelix pamoate 64 ACTOS ® 64 Anturol TM 64 By JENNIFER LEARN 64 Ampligen ® 64 3 registrational trial 64 peginterferon alpha 2a 64 Serdolect ® 64 Tarvacin TM 64 VeriStrat 64 Copegus ribavirin 64 tezampanel NGX# 64 EndoTAG TM -1 64 Enzastaurin 64 Antiviral Activity 64 HCV RESPOND 2 64 topically administered 64 PS# [001] 64 Interferon Gamma 64 albiglutide 64 Multiple Myeloma MM 64 Adalimumab 64 Gleevec resistant 64 Phase III Trial 64 INFERGEN 64 BIM #A# 64 Menadione 64 thetreatment 64 Moxifloxacin 64 pregabalin Lyrica 64 prospective nonrandomized 64 phosphatidylserine PS targeting 64 pegylated interferon alfa 2a 64 Oglemilast 64 EXPAREL ™ 64 drug GAP #B# 64 randomized multicenter trial 64 ancrod 64 Pivotal Trial 64 prospective multicenter study 64 Phase IIb Clinical Trial 64 NN# [001] 64 Valdoxan 64 Amplimexon 64 Phase 2b clinical 64 Octreotide 64 monoclonal antibody conjugated 64 Vicinium TM 64 investigational pan BCR 64 fluvastatin 64 PD LID 64 pharmacodynamic effects 64 ixabepilone 64 Dapagliflozin 64 Vascugel ® 64 multicenter clinical 64 RE SURGE 64 OMAPRO ™ 64 selective modulator 64 sodium thiosulfate STS 64 randomized Phase III 64 Lisofylline LSF 64 oxymorphone ER 64 Neupogen ® 64 Initiates Phase III 64 immune modulating 64 prospective multicenter 64 AQ4N 64 Oral Insulin 64 Tracleer R 64 refractory acute myeloid 64 #I TM# 64 PROSTVAC ® 64 refractory CLL 64 teduglutide 64 Elisabeth Lindner CEO 64 delivers fluocinolone acetonide FA 64 Cloretazine VNP#M 64 ENDEAVOR IV 64 gefitinib Iressa 64 Veronate 64 NCIC CTG 64 eltrombopag 64 mGluR5 NAM 64 Ketotransdel 64 antiproliferative effects 64 AeroLEF TM 64 assessing T DM1 64 HGS ETR1 mapatumumab 64 Sanvar 64 PI3K inhibitor 64 IND submission 64 orally inhaled 64 etanercept Enbrel 64 vernakalant hydrochloride 64 MYDICAR ® 64 biliary tract cancer 64 TACI Ig 64 vismodegib 64 buccal spray 64 PEGylated interferon beta 1a 64 XmAb# 64 Fast Track Status 64 Cancidas 64 Valortim R 64 pharmacokinetic pharmacodynamic PK PD 64 HSP# inhibitor 64 miglustat 64 Phase III Clinical Trials 64 DPX Survivac 64 CML CP 64 Solorel 64 Erlotinib 64 lenalidomide Revlimid 64 atacicept 64 isatoribine 64 intradermal injections 64 Cardiotoxicity 64 sulodexide 64 PSN# [001] 64 MVA MUC1 IL2 64 CCX# 64 Trastuzumab DM1 64 Xeloda ® 64 faropenem medoxomil 64 clotrimazole 64 chimeric monoclonal antibody 64 photoprotective drug 64 Cerebril TM 64 Humanized Anti 64 anti amnesic 64 docetaxel Taxotere R 64 unique alkylating agent 64 IMiDs ® 64 quetiapine fumarate 64 RH1 64 cetuximab Erbitux R 64 nalbuphine ER 64 Alequel 64 EGFR TKI 64 triphendiol 64 ibandronate 64 pharmacodynamic profile 64 Initiates Enrollment 64 PROCHYMAL 64 Gattex 64 sunitinib malate